UK partners with Novartis in linking R&D, reimbursement and manufacturing

January 15, 2020 Latest News News of the Day

This is a preview of subscriber content

Subscribe now to continue reading.

The explicit linking of R&D, reimbursement of a product and industry development policy through manufacturing marks a new development in the promotion of biopharmaceutical innovation. …

Subscribe now to continue reading.

Latest Video

If this makes you uncomfortable, it should, because it is the only correct response
September 16, 2025 - Latest News
Merck welcomes new director of market access, government affairs and communications
September 16, 2025 - Latest News
Ipsen appoints Dagmar Tschoep as general manager for Australia and New Zealand
September 16, 2025 - Latest News
New data reveals deep inequities as Sanofi rolls out trust-building initiative
September 17, 2025 - Latest News
Australian Dementia Network Registry wants access to 'turning point' therapies
September 17, 2025 - Latest News

UK partners with Novartis in linking R&D, reimbursement and manufacturing

This is a preview of subscriber content

Latest Video

Most Read

If this makes you uncomfortable, it should, because it is the only correct response

Merck welcomes new director of market access, government affairs and communications

Ipsen appoints Dagmar Tschoep as general manager for Australia and New Zealand

New data reveals deep inequities as Sanofi rolls out trust-building initiative

Australian Dementia Network Registry wants access to 'turning point' therapies

New Stories

If the minister is too embarrassed to respond, it might be the best of bad responses

Mark Butler acknowledges his concerns over potential impact of US pharmaceutical pricing reforms

CSL appoints new global head of search to accelerate innovation through strategic partnerships

Pharmacy Guild of Australia acquires Member Benefits Australia

Sanofi promotes a national dialogue on health literacy and trust

Island Pharmaceuticals reports breakthrough survival data for galidesivir in Marburg and Ebola studies

Australian Dementia Network Registry wants access to 'turning point' therapies

Sign In

UK partners with Novartis in linking R&D, reimbursement and manufacturing

This is a preview of subscriber content

Latest Video

Most Read

If this makes you uncomfortable, it should, because it is the only correct response

Merck welcomes new director of market access, government affairs and communications

Ipsen appoints Dagmar Tschoep as general manager for Australia and New Zealand

New data reveals deep inequities as Sanofi rolls out trust-building initiative

Australian Dementia Network Registry wants access to 'turning point' therapies

Follow Us

New Stories

If the minister is too embarrassed to respond, it might be the best of bad responses

Mark Butler acknowledges his concerns over potential impact of US pharmaceutical pricing reforms

CSL appoints new global head of search to accelerate innovation through strategic partnerships

Pharmacy Guild of Australia acquires Member Benefits Australia

Sanofi promotes a national dialogue on health literacy and trust

Island Pharmaceuticals reports breakthrough survival data for galidesivir in Marburg and Ebola studies

Australian Dementia Network Registry wants access to 'turning point' therapies